Agilent Technologies Inc

Latest articles

27d
Business Wire
CORRECTING and REPLACING Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancerexpress PD-L1 can now be identified for potential treatment with KEYTRUDA® (pem
Business Wire / Posted 27 days ago
express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by... Read more
5 related articles
27d
Business Wire
Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) CancerSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today
Business Wire / Posted 27 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by U.S. Food and Drug Administration (FDA), for use as an aid in identifying gastric or GEJ... Read more
5 related articles
30d
Business Wire
Agilent Technologies Joins with LabCentral to Help Advance Scientific Discoveryis a fast-growing market for Agilent, and Cambridge is a hub of innovation in t
Business Wire / Posted 30 days ago
is a fast-growing market for Agilent, and Cambridge is a hub of innovation in this field. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets.With more... Read more

In this news